Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06737575

Chest Trauma Scoring Systems as Predictors of Morbidity and Mortality in Iraq

This prospective observational study aims to evaluate the effectiveness of chest trauma scoring systems in predicting morbidity and mortality in patients with blunt chest trauma in Iraq. The primary questions it seeks to address are:

How accurately do chest trauma scoring systems predict mortality and critical outcomes such as ICU admission or the need for advanced interventions? How well do these scoring systems stratify patients based on injury severity in a resource-limited setting? Are there any demographic or clinical factors that impact the predictive performance of these scoring systems?

Participants will:

Be assessed using chest trauma scoring systems upon arrival at the emergency department to determine risk levels.

Have demographic and clinical data, including age, gender, injury mechanism, comorbidities, and length of hospital stay, collected to explore potential associations with outcomes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

College of Medicine - Al-Nahrain University

Baghdad, Iraq

Location contact

Abdul-Ilah R. Khamis

PRINCIPAL_INVESTIGATOR

Mesan A. Hijazy, Student

SUB_INVESTIGATOR

Murtaja Satea Shafeea, MD

SUB_INVESTIGATOR

Mustafa H. Alsaadi, Student

SUB_INVESTIGATOR

Sanarya N Abd-Al-Taj, Student

SUB_INVESTIGATOR

Yaser aamer Eisa Alhaibi, Assistant professor

CONTACT

[email protected]

009647705051684

About this study

Chest trauma is a major cause of morbidity and mortality, often resulting from motor vehicle accidents, falls, or physical assaults. It can lead to serious complications such as pulmonary contusions, rib fractures, and damage to thoracic organs. The Chest Trauma Score (CTS) helps assess injury severity by considering factors like age, number of rib fractures, and pulmonary contusion severity. Higher CTS values are associated with worse outcomes, such as prolonged mechanical ventilation and higher mortality rates. Early identification using this scoring system improves clinical decision-making and outcomes.

Despite the global utility of trauma scoring systems, there is limited research on their application in developing countries like Iraq, where trauma care is often constrained by limited resources and inconsistent protocols. In Iraq, blunt chest trauma is a prevalent issue due to frequent road traffic accidents and other causes. However, a lack of locally validated tools such as CTS hinders the ability of healthcare providers to assess injury severity accurately and predict outcomes.

This study aims to evaluate the effectiveness of the Chest Trauma Score in predicting morbidity and mortality among patients with blunt chest trauma in Iraq. By addressing this research gap, the findings will contribute to improving trauma care protocols, informing policy decisions, and enhancing the overall healthcare system's capacity to manage chest trauma effectively.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with blunt chest trauma.
  • Patients presenting to the emergency department within 4 hours.
  • Patients (or their legal representatives) must provide informed consent to participate in the study.
  • Patients who can be assessed using the Chest Trauma Score at the time of arrival (e.g., having stable enough vitals to allow for evaluation).

Exclusion criteria

  • Patients with penetrating chest trauma (e.g., gunshot or stab wounds), as the Chest Trauma Score is typically used for blunt trauma.
  • Patients presenting with chest conditions unrelated to trauma (e.g., pneumonia, COPD exacerbation, or other non-traumatic causes of chest pain or respiratory distress).
  • Patients with severe pre-existing comorbidities (e.g., end-stage heart failure, terminal cancer) where trauma is unlikely to be the primary cause of morbidity or mortality.
  • Patients with missing or incomplete clinical data, including imaging or vital signs necessary to calculate the CTS accurately.
  • Patients who refuse consent or do not agree to the use of their data for research purposes.

Treatment and study plan

Primary outcomes

  1. In hospital mortality

    Time frame: In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 30

    Mortality (death) during hospitalization.

  2. Accuracy Assessment of the Chest Trauma Score (CTS)

    Time frame: the first 4 hours after ER admission

    The total score ranges from 2 to 12, with higher scores indicating worse outcomes.

Secondary outcomes

  1. Number of Participants Requiring ICU Admission

    Time frame: Up to discharge, an average of 10 days

    The requirement for admission to the intensive care unit (ICU) is determined by the presence of severe clinical deterioration, significant complications, or the need for advanced monitoring and life-support measures.

Study contacts

Contact information is provided by the study sponsor or research team.

Abdul-Ilah R. Khamis

CONTACT

[email protected]

+9647838571013

Sponsors and collaborators

Lead sponsor

Al-Nahrain University

Other

Registry information

Official study title

Validation of Chest Trauma Scoring Systems in Predicting Blunt Chest Injury Outcomes in Iraq: A Prospective Study

Acronym: CTS

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 17, 2024
Registry last updated
Mar 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.